Geode Capital Management
UTHR icon

Geode Capital Management’s United Therapeutics UTHR Stock Holding History

Geode Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$730M Buy
1,233,029
+39,965
+3% +$19.9M 0.05% 344
2025
Q4 		$580M Sell
1,193,064
-56,596
-5% -$26.4M 0.04% 397
2025
Q3 		$523M Buy
1,249,660
+49,295
+4% +$16.6M 0.03% 415
2025
Q2 		$344M Sell
1,200,365
-23,628
-2% -$7.06M 0.02% 498
2025
Q1 		$377M Buy
1,223,993
+85,701
+8% +$29.4M 0.03% 460
2024
Q4 		$401M Buy
1,138,292
+44,277
+4% +$16.3M 0.03% 443
2024
Q3 		$391M Buy
1,094,015
+45,566
+4% +$15.4M 0.03% 446
2024
Q2 		$334M Buy
1,048,449
+220,178
+27% +$58.3M 0.03% 451
2024
Q1 		$190M Buy
828,271
+48,509
+6% +$10.9M 0.02% 616
2023
Q4 		$171M Sell
779,762
-50,484
-6% -$11.6M 0.02% 605
2023
Q3 		$187M Buy
830,246
+23,865
+3% +$5.5M 0.02% 548
2023
Q2 		$178M Buy
806,381
+47,238
+6% +$10.5M 0.02% 560
2023
Q1 		$170M Buy
759,143
+98,267
+15% +$24.2M 0.02% 553
2022
Q4 		$184M Buy
660,876
+29,137
+5% +$7.36M 0.03% 518
2022
Q3 		$132M Sell
631,739
-5,274
-0.8% -$1.18M 0.02% 594
2022
Q2 		$150M Sell
637,013
-5,754
-0.9% -$1.17M 0.02% 558
2022
Q1 		$115M Sell
642,767
-118,181
-16% -$22.5M 0.01% 704
2021
Q4 		$164M Buy
760,948
+62,882
+9% +$12.3M 0.02% 598
2021
Q3 		$129M Sell
698,066
-11,713
-2% -$2.31M 0.02% 670
2021
Q2 		$127M Buy
709,779
+45,260
+7% +$8.62M 0.02% 675
2021
Q1 		$111M Buy
664,519
+5,620
+0.9% +$937K 0.02% 705
2020
Q4 		$100M Buy
658,899
+55,777
+9% +$7.32M 0.02% 692
2020
Q3 		$60.9M Sell
603,122
-16,707
-3% -$1.83M 0.01% 811
2020
Q2 		$75M Buy
619,829
+38,141
+7% +$4.29M 0.02% 677
2020
Q1 		$55.2M Buy
581,688
+41,999
+8% +$3.99M 0.01% 721
2019
Q4 		$47.5M Buy
539,689
+25,241
+5% +$2.22M 0.01% 970
2019
Q3 		$41M Sell
514,448
-2,870
-0.6% -$231K 0.01% 993
2019
Q2 		$40.4M Sell
517,318
-56,290
-10% -$5.26M 0.01% 1003
2019
Q1 		$67.3M Sell
573,608
-22,007
-4% -$2.56M 0.02% 702
2018
Q4 		$64.8M Buy
595,615
+10,863
+2% +$1.26M 0.02% 623
2018
Q3 		$74.7M Sell
584,752
-2,435
-0.4% -$301K 0.02% 618
2018
Q2 		$66.4M Sell
587,187
-27,475
-4% -$3.02M 0.02% 639
2018
Q1 		$69M Sell
614,662
-70,697
-10% -$8.98M 0.02% 608
2017
Q4 		$101M Sell
685,359
-61,965
-8% -$7.88M 0.03% 480
2017
Q3 		$87.6M Buy
747,324
+47,409
+7% +$6.05M 0.03% 497
2017
Q2 		$90.8M Buy
699,915
+40,209
+6% +$5.02M 0.04% 471
2017
Q1 		$89.3M Buy
659,706
+66,912
+11% +$10.1M 0.04% 463
2016
Q4 		$85M Buy
592,794
+36,623
+7% +$4.68M 0.04% 428
2016
Q3 		$65.7M Buy
556,171
+29,543
+6% +$3.55M 0.03% 490
2016
Q2 		$55.8M Buy
526,628
+70,909
+16% +$7.91M 0.03% 509
2016
Q1 		$50.8K Buy
455,719
+79,502
+21% +$10.1M 0.03% 526
2015
Q4 		$58.9M Buy
376,217
+51,922
+16% +$7.56M 0.03% 475
2015
Q3 		$42.5M Sell
324,295
-29,691
-8% -$4.76M 0.03% 551
2015
Q2 		$61.5M Buy
353,986
+5,583
+2% +$1M 0.04% 470
2015
Q1 		$60.1M Buy
348,403
+20,178
+6% +$3.08M 0.03% 468
2014
Q4 		$42.5M Buy
328,225
+12,210
+4% +$1.57M 0.03% 543
2014
Q3 		$40.7M Buy
316,015
+17,048
+6% +$1.76M 0.03% 533
2014
Q2 		$26.5M Buy
298,967
+18,536
+7% +$1.78M 0.02% 704
2014
Q1 		$26.4M Buy
280,431
+1,673
+0.6% +$171K 0.02% 693
2013
Q4 		$31.5M Buy
278,758
+8,818
+3% +$795K 0.02% 589
2013
Q3 		$21.3M Buy
269,940
+5,967
+2% +$436K 0.02% 671
2013
Q2 		$17.4M Buy
+263,973
New +$17M 0.02% 685

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Geode Capital Management's UTHR Position: Q1 2026 in Review

Geode Capital Management increased its United Therapeutics (UTHR) stake by 3.3% in Q1 2026, buying an estimated $19.9M and bringing the position to 1,233,029 shares worth $730M. The position accounts for 0.05% of the portfolio, ranked #344.

Geode Capital Management first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Geode Capital Management held 1,233,029 shares of United Therapeutics worth $730M as of Q1 2026.
  • Geode Capital Management bought 39,965 United Therapeutics shares in Q1 2026, an estimated $19.9M.
  • United Therapeutics made up 0.05% of Geode Capital Management's portfolio in Q1 2026, its #344 holding.
  • Geode Capital Management first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.